# Regulus Therapeutics (stock symbol: RGLS) Logo in transparent PNG and SVG formats

## Regulus Therapeutics Logo large

### Regulus Therapeutics Logo large Download PNG (42.78 KB)

![Regulus Therapeutics Logo large Download PNG (42.78 KB)](/img/orig/RGLS_BIG-d71b3372.png)

### Regulus Therapeutics Logo large Download SVG (6.58 KB)

![Regulus Therapeutics Logo large Download SVG (6.58 KB)](/img/orig/RGLS_BIG-5ce77103.svg)

## Regulus Therapeutics Logo icon format

### Regulus Therapeutics Logo icon format Download PNG (47.31 KB)

![Regulus Therapeutics Logo icon format Download PNG (47.31 KB)](/img/orig/RGLS-1e07d43c.png)

### Regulus Therapeutics Logo icon format Download SVG (4.16 KB)

![Regulus Therapeutics Logo icon format Download SVG (4.16 KB)](/img/orig/RGLS-6202e1d1.svg)

## Regulus Therapeutics Logo large for dark backgrounds

### Regulus Therapeutics Logo large for dark backgrounds Download PNG (42.42 KB)

![Regulus Therapeutics Logo large for dark backgrounds Download PNG (42.42 KB)](/img/orig/RGLS_BIG.D-1e5d6a49.png)

### Regulus Therapeutics Logo large for dark backgrounds Download SVG (6.35 KB)

![Regulus Therapeutics Logo large for dark backgrounds Download SVG (6.35 KB)](/img/orig/RGLS_BIG.D-e71b2232.svg)

## About Regulus Therapeutics

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

1. Website domain: regulusrx.com
2. Employees: 26
3. Marketcap: $22.48 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
